购物车

搜索结果

Search Results for " blk "

20

抑制剂 & 化合物

2

重组蛋白

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T26817 Bim-BLK-A

Bim Blocker A,Compound A,Bim BLK A,BimBLKA

Bim-BLK-A efficiently blocks Bim-induced apoptosis after Bax is activated on the mitochondria. The cellular target of Bim-BLK-A was identified to be the succinate dehydrogenase subunit B (SDHB) protein of complex II of the mitochondrial electron transfer
T73366 BLK-IN-2

BLK-IN-2为一种高效、选择性且不可逆的B-淋巴酪氨酸激酶(BLK)抑制剂,具有5.9 nM的IC50值。该化合物亦能抑制BTK,其IC50值为202.0 nM。BLK-IN-2在多种淋巴瘤细胞中展现出显著的抗增殖作用。
T63959 BLK-IN-1

BLK-IN-1 是一种选择性的、共价的 B-淋巴酪氨酸激酶 (BLK) 和 BTK 抑制剂,他们的 IC50 值分别为 18.8 nM 和 20.5 nM。BLK-IN-1 能够用于研究癌症。
T9072 Tuxobertinib

BDTX-189

EGFR; HER; BTK; RIP kinase Angiogenesis; Apoptosis; JAK/STAT signaling; NF-κB; Tyrosine Kinase/Adaptors
Tuxobertinib (BDTX-189) 是一种高效可口服的选择性 EGFR 和 HER2变构突变抑制剂,具有抗癌活性。它对 EGFR、HER2、BLK 和 RIPK2 的 KD 值分别为 0.2、0.76、13 和 1.2 nM。
T6078 Saracatinib

AZD0530,塞卡替尼

EGFR; Src; BTK; Autophagy Angiogenesis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors
Saracatinib (AZD0530) 是一种有效的 Src 抑制剂,抑制 c-Src、Lck、c-YES、Lyn、Fyn、Fgr 和 Blk 的 IC50值在 2.7 到 11 nM 之间,对其他酪氨酸激酶具有选择性。
T14692 BMX-IN-1

BMX kinase inhibitor

BTK Angiogenesis; Tyrosine Kinase/Adaptors
BMX-IN-1 (BMX kinase inhibitor) 是 X 染色体上的骨髓酪氨酸激酶 (BMX, IC50 = 8 nM) 和相关的布鲁顿酪氨酸激酶 (BTK, IC50 = 10.4 nM) 的特异性抑制剂,但 BMX-IN-1 对 Blk、JAK3、EGFR、Itk 或 Tec 活性的效力要低 47-656 倍以上。
T71819 RK-20448

RK-20448 is an ATP-competitive inhibitor of Lck, Src, KDR/VEGF2R, and Tie-2. It also inhibits BLK, Csk, Fyn, and Lyn. RK-20448 is the cis isomer of A-419259
T39129 BMS-986143

BMS-986143 是一种口服有效的、可逆的BTK 抑制剂,IC50为 0.26 nM,具有自身免疫性疾病的研究潜力。BMS-986143 还抑制 TEC、BLK、BMX、TXK FGR、YES1、ITK,IC50分别为 3 nM、5 nM、7 nM、10 nM、15 nM、19 nM、21 nM。
T74642 DB1113

PROTACs PROTAC
DB1113 (Example 24) 是一种靶向蛋白激酶降解的双功能化合物。DB1113 可降解 ABL1,ABL2,BLK,CDK11B,CDK4,CSK,EPHA3,FER,GAK,LIMK1,MAP3K20,MAP4K1,MAP4K2,MAP4K3,MAP4K5,MAPK14,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,NLK,PDIK1L,PTK2B,RIPK1,RPS6KA1,RPS6KA3,SIK2,SIK3,STK35,TNK2 和 ULK1。DB1113 可用于研究异常激酶活性介导的疾病或紊乱。
T7819 TAS0728

EGFR; HER Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
TAS0728 是一种 HER2 抑制剂,与HER2的 C805 位点共价结合,IC50值为 13 nM。它抑制 HER2、HER3 及其下游效应蛋白的磷酸化,具有抗肿瘤活性。
T10802 CHMFL-EGFR-202

EGFR Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
CHMFL-EGFR-202 是一种有效、不可逆的表皮生长因子受体 (EGFR) 突变型激酶抑制剂, 对耐药突变型 EGFR T790M 和 WT EGFR 激酶作用的 IC50 分别为 5.3 nM 和 8.3 nM。
T74644 DB0614

PROTACs PROTAC
DB1113 (Example 24) 是一种靶向蛋白激酶降解的双功能化合物。DB1113 可降解ABL1,ABL2,BLK,CDK11B,CDK4,CSK,EPHA3,FER,GAK,LIMK1,MAP3K20,MAP4K1,MAP4K2,MAP4K3,MAP4K5,MAPK14,MAPK7,MAPK8,MAPK9,MAPKAPK2,MAPKAPK3,NLK,PDIK1L,PTK2B,RIPK1,RPS6KA1,RPS6KA3,SIK2,SIK3,STK35,TNK2 和ULK1。DB1113 可用于研究异常激酶活性介导的疾病或紊乱。
T5138 BMS-986142

BTK Angiogenesis; Tyrosine Kinase/Adaptors
BMS986142 是一种有效的、具有高选择性的 Bruton's 酪氨酸激酶 (BTK)可逆性抑制剂 (IC50:0.5 nM)。
T1835 Ibrutinib

伊布替尼,依鲁替尼,PCI-32765

Tyrosine Kinases; Src; BTK; Ligands for Target Protein for PROTAC Angiogenesis; PROTAC; Tyrosine Kinase/Adaptors
Ibrutinib (PCI-32765) 是一种不可逆的、选择性的 Btk 抑制剂,IC50=0.5 nM,它是一种 Btk 配体,用于合成一系列 PROTAC 分子,如 P13I。P13I 作用于人 Burkitt’s 淋巴瘤 RAMOS 细胞,浓度为 10 和 100 nM 时,分别降解 73% 和 89% Btk。
T12542 Rilzabrutinib

PRN1008

EGFR; Others; HER; BTK Angiogenesis; JAK/STAT signaling; Others; Tyrosine Kinase/Adaptors
Rilzabrutinib (PRN1008) 是一种可逆的、选择性的、有口服活性的布鲁顿氏酪氨酸激酶(BTK)共价抑制剂,其 IC50=1.3 nM。
T13564L AZ7550 hydrochloride

AZ7550 hydrochloride (1421373-99-0 free base)

EGFR; IGF-1R Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
AZ7550 hydrochloride (AZ7550 hydrochloride ) 是 AZD9291 的活性代谢物,可抑制 IGF1R 活性,IC50为 1.6 μM。
T13564 AZ7550

MLK; FAK; EGFR; FLT; Tyrosine Kinases; PYK2; MNK; IGF-1R; ACK; BTK; ALK; Drug Metabolite Angiogenesis; Cytoskeletal Signaling; JAK/STAT signaling; MAPK; Metabolism; Tyrosine Kinase/Adaptors
AZ7550 是 AZD9291 的活性代谢物,可抑制 IGF1R 活性,IC50为 1.6 μM。
T16578 PRN694

Others Others
PRN694 shows extended target residence time on ITK and RLK, enabling durable attenuation of effector cells in vitro and in vivo. PRN694 is an irreversible, highly selective, and effective covalent interleukin-2-inducible T-cell kinase (ITK) and resting ly
T10801 CHMFL-ABL/KIT-155

CHMFL-ABL-KIT-155

c-Kit Tyrosine Kinase/Adaptors
CHMFL-ABL/KIT-155 is a highly potent and orally active type II ABL/c-KIT dual kinase inhibitor (IC50s: 46 nM/75 nM). It arrests cell cycle progression and induces apoptosis.
T18049 Ibrutinib-biotin

Others Others
Ibrutinib-biotin is a probe that consists of Ibrutinib linked to biotin via a long chain linker, has an IC50 of 0.755-1.02 nM for BTK.

化合物

Bim-BLK-A
Cat.No: T26817
Synonym: Bim Blocker A,Compound A,Bim BLK A,BimBLKA
Target:
BLK-IN-2
Cat.No: T73366
Synonym:
Target:
BLK-IN-1
Cat.No: T63959
Synonym:
Target:
Tuxobertinib
Cat.No: T9072
Synonym: BDTX-189
Target: EGFR, HER, BTK, RIP kinase
Saracatinib
Cat.No: T6078
Synonym: AZD0530,塞卡替尼
Target: EGFR, Src, BTK, Autophagy
BMX-IN-1
Cat.No: T14692
Synonym: BMX kinase inhibitor
Target: BTK
RK-20448
Cat.No: T71819
Synonym:
Target:
BMS-986143
Cat.No: T39129
Synonym:
Target:
DB1113
Cat.No: T74642
Synonym:
Target: PROTACs
TAS0728
Cat.No: T7819
Synonym:
Target: EGFR, HER
CHMFL-EGFR-202
Cat.No: T10802
Synonym:
Target: EGFR
DB0614
Cat.No: T74644
Synonym:
Target: PROTACs
BMS-986142
Cat.No: T5138
Synonym:
Target: BTK
Ibrutinib
Cat.No: T1835
Synonym: 伊布替尼,依鲁替尼,PCI-32765
Target: Tyrosine Kinases, Src, BTK, Ligands for Target Protein for PROTAC
Rilzabrutinib
Cat.No: T12542
Synonym: PRN1008
Target: EGFR, Others, HER, BTK
AZ7550 hydrochloride
Cat.No: T13564L
Synonym: AZ7550 hydrochloride (1421373-99-0 free base)
Target: EGFR, IGF-1R
AZ7550
Cat.No: T13564
Synonym:
Target: MLK, FAK, EGFR, FLT, Tyrosine Kinases, PYK2, MNK, IGF-1R, ACK, BTK, ALK, Drug Metabolite
PRN694
Cat.No: T16578
Synonym:
Target: Others
CHMFL-ABL/KIT-155
Cat.No: T10801
Synonym: CHMFL-ABL-KIT-155
Target: c-Kit
Ibrutinib-biotin
Cat.No: T18049
Synonym:
Target: Others
Cat. No. Product Name Species Expression System
TMPJ-00307 BLK Protein, Human, Recombinant (His)

Tyrosine-Protein Kinase Blk,BLK,B Lymphocy...

Human E. coli
Tyrosine-Protein Kinase Blk (BLK) contains one protein kinase domain, one SH2 domain and one SH3 domain. BLK is a non-receptor tyrosine kinase, which is involved in B-lymphocyte development, differentiation and signaling. B-cell receptor (BCR) signaling requires a tight regulation of several protein tyrosine kinases and phosphatases, and associated coreceptors. Signaling through BLK plays an important role in transmitting signals through surface immunoglobulines and supports the pro-B to pre-B t...
TMPY-04388 BLK Protein, Human, Recombinant (GST)

MODY11,BLK proto-oncogene, Src family tyrosine kina...

Human Baculovirus Insect Cells
Tyrosine-protein kinase Blk, also known as B lymphocyte kinase, p55-Blk and BLK, is a member of theprotein kinase superfamily, Tyr protein kinase family and SRC subfamily. BLK / p55-Blk is expressed in lymphatic organs, pancreatic islets, Leydig cells, striate ducts of salivary glands and hair follicles. BLK / p55-Blk is a src-family protein tyrosine kinase specifically expressed in B-lineage cells of mice. The early onset of Blk expression during B-cell development in the bone marrow and...

重组蛋白

BLK Protein, Human, Recombinant (His)
Cat.No: TMPJ-00307
Species: Human
Expression System: E. coli
BLK Protein, Human, Recombinant (GST)
Cat.No: TMPY-04388
Species: Human
Expression System: Baculovirus Insect Cells
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼